Leong Xin Yi, Gopinath Divya, Syeed Sakil M, Veettil Sajesh K, Shetty Naresh Yedthare, Menon Rohit Kunnath
School of Dentistry, International Medical University, Kuala Lumpur 57000, Malaysia.
Department of Basic Medical and Dental Sciences, College of Dentistry, Ajman University, Ajman P.O. Box 346, United Arab Emirates.
J Clin Med. 2023 Apr 7;12(8):2763. doi: 10.3390/jcm12082763.
This systematic review and network meta-analysis aimed to assess comparative efficacy and safety of interventions to treat symptomatic, biopsy-proven oral lichen planus (OLP).
Search was conducted for trials published in Medline, Embase and Cochrane Central Register of Controlled Trials. Network meta-analysis was performed on data from randomized controlled trials that assessed efficacy and safety of interventions used in the treatment of OLP. Agents were ranked according to their effectiveness in treatment of OLP based on outcomes using surface under the cumulative ranking [SUCRA].
In total, 37 articles were included in the quantitative analysis. Purslane was clinically significant and ranked first in improving clinical symptoms [RR = 4.53; 95% CI: 1.45, 14.11], followed by aloe vera [RR = 1.53; 95% CI: 1.05, 2.24], topical calcineurin [RR = 1.38; 95% CI: 1.06, 1.81] and topical corticosteroid [RR = 1.35 95% CI: 1.05, 1.73]. Topical calcineurin demonstrated the highest incidence of adverse effects [RR, 3.25 [95% CI: 1.19, 8.86. Topical corticosteroids were significant in achieving clinical improvement of OLP with RR1.37 [95% CI: 1.03, 1.81]. PDT [MD = -5.91 [95% CI: -8.15, -3.68] and showed statistically significant improvement in the clinical score for OLP.
Purslane, aloe vera and photodynamic therapy appear promising in treatment of OLP. More high-quality trials are recommended for strengthening the evidence. Although topical calcineurin is significantly efficacious in the treatment of OLP, significant adverse effects are a concern for clinical use. Based on the current evidence, topical corticosteroids are recommended for treatment of OLP owing to their predictable safety and efficacy.
本系统评价和网状Meta分析旨在评估治疗有症状、活检证实的口腔扁平苔藓(OLP)的干预措施的相对疗效和安全性。
检索了发表在Medline、Embase和Cochrane对照试验中央注册库中的试验。对评估治疗OLP所用干预措施疗效和安全性的随机对照试验数据进行网状Meta分析。根据基于累积排序曲线下面积(SUCRA)的结果,对药物在治疗OLP方面的有效性进行排序。
定量分析共纳入37篇文章。马齿苋在改善临床症状方面具有临床显著性且排名第一[风险比(RR)=4.53;95%置信区间(CI):1.45,14.11],其次是芦荟[RR = 1.53;95% CI:1.05,2.24]、外用钙调神经磷酸酶抑制剂[RR = 1.38;95% CI:1.06,1.81]和外用糖皮质激素[RR = 1.35,95% CI:1.05,1.73]。外用钙调神经磷酸酶抑制剂的不良反应发生率最高[RR,3.25[95% CI:1.19,8.86]。外用糖皮质激素在实现OLP临床改善方面具有显著性,RR为1.37[95% CI:1.03,1.81]。光动力疗法(PDT)[均差(MD)=-5.91[95% CI:-8.15,-3.68],且在OLP临床评分方面显示出统计学上的显著改善。
马齿苋、芦荟和光动力疗法在治疗OLP方面似乎很有前景。建议开展更多高质量试验以加强证据支持。尽管外用钙调神经磷酸酶抑制剂在治疗OLP方面显著有效,但严重的不良反应是临床应用中需要关注的问题。基于目前的证据,由于外用糖皮质激素安全性和疗效可预测,推荐用于治疗OLP。